BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Basilea Pharmaceutica Initiates Next Phase 1 Multiple Ascending Dose Study With Antibiotic Bal30072 Active Against Multidrug-Resistant Gram-Negative Bacteria

  November 26, 2012

   · 

  3 min read
• BioMidwest

  Mirada Medical Presents Multi-Modal Quantitative Reading Exhibit at the Radiological Society of North America (RSNA) Annual Meeting

  November 26, 2012

   · 

  2 min read
• Business

  Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) Enters Into Collaboration for the Development of Additional Exon-Skipping Product for Duchenne Muscular Dystrophy

  November 26, 2012

   · 

  7 min read
• Business

  Arvind Vasudeva is New CEO of Aurobindo Pharma

  November 26, 2012

   · 

  1 min read
• Pharm Country

  Ranbaxy Laboratories Launches Absorica™ (Isotretinoin) Capsules in the U.S. Healthcare Market

  November 26, 2012

   · 

  5 min read
• Deals

  Baxter International, Inc. Pursues $4 Billion Bid for Gambro AB

  November 26, 2012

   · 

  1 min read
• Policy

  FDA Says Johnson & Johnson’s TB Drug Appears Safe

  November 26, 2012

   · 

  1 min read
• BioMidwest

  Abbott Laboratories Announces Pricing of AbbVie’s $14.7 Billion Private Placement Notes Offering

  November 26, 2012

   · 

  4 min read
• FDA

  Novo Nordisk A/S Upbeat on Tresiba Insulin’s U.S. Prospects

  November 26, 2012

   · 

  1 min read